NEW YORK, Sept. 12 -- Drugmaker Bristol-Myers Squibb Co. pushed out its chief executive, Peter R. Dolan, on Tuesday at the urging of a federal monitor who was looking into how top management dealt with generic competition for Plavix, its top-selling heart drug. -
Bristol-Myers Ousts Its Chief at Monitor's Urging
NEW YORK, Sept. 12 -- Drugmaker Bristol-Myers Squibb Co. pushed out its chief executive, Peter R. Dolan, on Tuesday at the urging of a federal monitor who was looking into how top management dealt with generic competition for Plavix, its top-selling heart drug.-
By Brooke A. Masters